
If you run a primary care group, an ACO, or a Medicare Advantage plan, you’ve felt the tension: chronic disease is eating your day alive, but the “visit-based” system still rewards you for the moment, not the month.
The 2026 Medicare Physician Fee Schedule (PFS) changes don’t magically fix that. But they do something important: they reinforce that CMS is not treating remote care like a side quest. CMS is doubling down on ongoing, outcomes-driven virtual care that keeps people stable at home, while making it easier for practices to operationalize it at scale.
And that is exactly where Welby plays.
One of the biggest misunderstandings in the market is treating Remote Patient Monitoring (RPM) as “telehealth.” CMS is explicit that RPM and RTM are inherently non-face-to-face services and sit outside the statutory definition of “Medicare telehealth services.”
That matters because it keeps RPM from getting whiplashed by telehealth politics and temporary waivers. It positions remote care as a durable part of how Medicare expects chronic disease to be managed: continuously, proactively, and measurably.
In 2026, CMS finalized major updates to remote monitoring valuation, including new RPM codes created by CPT to describe data transmission and updated valuation approaches for device supply.
A few highlights that should matter to any operator building serious virtual care:
This is why I keep saying: “RPM isn’t a gadget business.” The most valuable part is the care. Medicare is paying to support the work of keeping someone stable between visits, not just shipping a cuff.
Here’s the hard truth: plenty of RPM programs have been little more than billing engines.
The industry created a cottage economy of:
Medicare’s 2026 direction pushes against that. When CMS protects clinical work RVUs for monitoring time and invests in more structured code definitions, they’re implicitly saying: this is supposed to be real longitudinal care.
That reinforces a simple idea: if your virtual care vendor isn’t moving clinical metrics and reducing downstream utilization, you’re not running a care program. You’re running a spreadsheet.
Traditional office-based care is episodic by design: a visit, a plan, a hope that life cooperates.
Remote care codes pay differently because they represent a different kind of medicine: frequent measurement, fast feedback loops, and proactive intervention. The reimbursement structure is built around the month, not the moment. And in 2026, CMS didn’t retreat from that. They strengthened it with new RPM code structure and valuation decisions that reinforce ongoing care delivery.
There’s also a bigger macro-signal in the 2026 PFS: conversion factors increased, and CMS is now applying two separate conversion factors beginning in 2026 (with a higher update for qualifying APM participants). That’s CMS telling the market, “we will pay more for accountability.”
If you’re a customer deciding whether to build high-performing virtual care, that’s not noise. That’s the runway getting longer.
Let’s talk dollars in a way that actually maps to decisions.
For a practice or value-based organization, remote care programs create three financial levers:
And we should be honest: if your program isn’t improving utilization, the rest of the economics will eventually get squeezed.
One of our clients launched an RPM hypertension cohort with Welby, and the results have been decisive:
That is not “nice engagement.” That is risk coming under control.
Here’s why that should make any CFO and any CMO lean in.
AHRQ’s HCUP analysis puts the average cost of a treat-and-release ED visit at about $750 (2021 national estimate).
CDC’s “Health, United States” reports the average adjusted cost per inpatient stay at community hospitals at $14,101 (2019).
So even with conservative math, the savings potential is meaningful.
A simple, transparent savings frame (illustrative):
That’s ~$35,700 in avoided acute-care cost from a relatively small utilization shift. And hypertension is not a small problem. CDC notes 1.1 million ED visits where essential hypertension is the primary diagnosis (national estimate).
Now scale that logic across thousands of members, and you see why CMS is bullish: the “expense” of proactive monthly care is tiny compared to the cost of preventable acute events.
Access isn’t just “virtual visits exist.” Access is:
The 2026 code structure and valuation shifts reward programs that can do that reliably.
And that’s the Welby thesis: remote care should be clinically excellent, operationally tight, and financially aligned with outcomes.
Welby isn’t a device company. We’re a remote care operating system that makes RPM work the way it was intended:
If you’re a customer running a “checkbox RPM program,” 2026 is your wake-up call. CMS is building for the long term. The market is going to keep separating into two buckets:
If you want to talk about what “good virtual care” looks like in 2026, and what it takes to get to stable BP fast, Welby’s ready.